International Biotechnology Trust’s Ascendis Pharma A/S ASND Stock Holding History

International Biotechnology Trust’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-29,400	Closed	-$3.15M	–	64
2023 Q1	$3.15M	Hold	29,400	–	–	0.88%	34
2022 Q4	$3.59M	Hold	29,400	–	–	1.11%	27
2022 Q3	$3.04M	Buy	29,400 +26,667	+976%	+$2.53M	0.97%	33
2022 Q2	$29.4K	Sell	2,733 -26,667	-91%	-$2.51M	0.31%	57
2022 Q1	$1.95M	Hold	29,400	–	–	0.44%	44
2021 Q4	$3.96M	Hold	29,400	–	–	0.88%	31
2021 Q3	$4.69M	Buy	29,400 +15,600	+113%	+$2.13M	1.13%	25
2021 Q2	$1.81M	Hold	13,800	–	–	0.48%	41
2021 Q1	$1.77M	Hold	13,800	–	–	0.47%	35
2020 Q4	$2.3M	Hold	13,800	–	–	0.63%	31
2020 Q3	$2.13M	Hold	13,800	–	–	0.69%	28
2020 Q2	$2M	Hold	13,800	–	–	0.66%	28
2020 Q1	$1.55M	Hold	13,800	–	–	0.71%	26
2019 Q4	$1.92M	Hold	13,800	–	–	0.69%	33
2019 Q3	$1.33M	Sell	13,800 -12,000	-47%	-$1.34M	0.61%	31
2019 Q2	$2.97M	Buy	25,800 +12,000	+87%	+$1.44M	1.1%	25
2019 Q1	$1.62M	Buy	+13,800	New	+$1.21M	0.6%	44

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

International Biotechnology Trust's ASND Position: Q2 2023 in Review

International Biotechnology Trust sold out of Ascendis Pharma A/S (ASND) in Q2 2023, closing a stake of 29,400 shares — an estimated $3.15M sold.

International Biotechnology Trust first reported a position in ASND in Q1 2019 and held it in 17 quarters. The position peaked at $4.69M in Q3 2021. 157 funds tracked by Wall St. Rank hold ASND as of Q2 2023.

International Biotechnology Trust reported no remaining Ascendis Pharma A/S position as of Q2 2023 after selling out during the quarter.
International Biotechnology Trust sold 29,400 Ascendis Pharma A/S shares in Q2 2023, an estimated $3.15M.
International Biotechnology Trust first reported a position in Ascendis Pharma A/S in Q1 2019 and held it in 17 quarters.
International Biotechnology Trust's Ascendis Pharma A/S position peaked at $4.69M in Q3 2021.
157 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2023.

Based on International Biotechnology Trust's 13F filing for Q2 2023, filed 8 Aug 2023.